U.S. President Donald Trump said on Tuesday he intends to impose a "25% or higher" levies on semiconductors and ...

In fiscal 2024, the exports to the U.S. were worth $8.7 billion, or about 31% of total pharma exports, per data from government-backed trade body Pharmexcil. Trump's threat to raise tariffs sent ...

U.S. President Donald Trump's proposed tariffs on semiconductors and pharmaceutical imports threaten India's generics industry, a major supplier to the U.S. market. With 31% of their exports sent to ...

Indian pharmaceutical companies will be able to retain their dominant market share in the U.S. in selling generic drugs even ...

Sun Pharmaceutical Industries Ltd. closed 16.18% short of its 52-week high of 1,960.20 rupees, which the company reached on ...

Stay up-to-date with the Sun Pharma Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on ...

Healthcare stocks were trading in the negative zone, with the BSE Healthcare index falling 733.35 points or 1.82% at 39530.34 at 13:45 IST.

Citi Research said it's for the good to avoid Lupin Ltd. and Aurobindo Pharma Ltd. which have heavy generic drugs portfolios.

India, which calls itself the 'pharmacy of the world', makes cheaper generic versions of complex innovative drugs in its ...

The US is India’s largest export market for pharmaceuticals, accounting for over 30% of overall pharma exports in FY23-24 at $8.7 billion ...

Sun Pharmaceutical Industries Ltd. closed 14.82% short of its 52-week high of 1,960.20 rupees, which the company reached on ...

Trump’s tariff threats have sent shockwaves through Indian pharma stocks, but analysts argue the real casualty could be the US healthcare system. With India supplying nearly half of US generics, ...